BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1537081)

  • 1. Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation.
    Liang R; Chan TK; Chiu E; Todd D
    Cancer Chemother Pharmacol; 1992; 29(4):323-5. PubMed ID: 1537081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extramedullary blast crisis in chronic myeloid leukemia.
    Specchia G; Palumbo G; Pastore D; Mininni D; Mestice A; Liso V
    Leuk Res; 1996; 20(11-12):905-8. PubMed ID: 9009247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha.
    Ambrosetti A; Krampera M; Veneri D; Meneghini V; Aprili F; Martinelli G; Pizzolo G; Perona G
    Int J Clin Lab Res; 1994; 24(1):58-9. PubMed ID: 8180425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the lymphoid blast crisis of chronic myeloid leukemia.
    Bassan R; Battista R; Comotti B; Minetti B; Chisesi T; Dini E; Barbui T
    Eur J Cancer Clin Oncol; 1987 May; 23(5):513-5. PubMed ID: 3477457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
    Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
    Kitajima K; Adachi T; Takahashi I; Nakada H; Osada K; Fukuda S; Ohmoto E; Aoyama S; Yorimitsu S; Sanada H
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3573-9. PubMed ID: 2817908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
    Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
    Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
    Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
    [No Abstract]   [Full Text] [Related]  

  • 10. FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
    Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani PL; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):173-6. PubMed ID: 8724545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of 158 cases of adult acute leukaemia: factors influencing prognosis and treatment response.
    Januszewicz E; Firkin FC; Chesterman CN; Garson OM; Beswick W; Keating MJ; Penington DG
    Aust N Z J Med; 1982 Jun; 12(3):238-45. PubMed ID: 6956290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrophy of the granular layer of the cerebellar cortex in patients with nonlymphoblastic leukemia treated with cytosine arabinoside].
    Nowacki P; Dolińska D; Honczarenko K; Zyluk B
    Neurol Neurochir Pol; 1992; 26(4):482-9. PubMed ID: 1484574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea.
    Lazzarino M; Morra E; Brusamolino E; Alessandrino EP; Orlandi E; Pagnucco G; Castagnola C; Bernasconi P; Merante S; Bonfichi M
    Hematol Oncol; 1991; 9(6):299-305. PubMed ID: 1748396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
    Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
    Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy for acute lymphocytic leukaemia in 25 adults.
    de Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H
    Blut; 1982 Mar; 44(3):151-8. PubMed ID: 6952951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia.
    Koller CA; Kantarjian HM; Feldman EJ; O'Brien S; Rios MB; Estey E; Keating M
    Cancer; 1999 Dec; 86(11):2246-51. PubMed ID: 10590364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.